IT-11.23.B: Quick Inventory of Depressive Symptomatology (QIDS)

IT-11.23.b: Quick Inventory of Depressive Symptomatology (QIDS)

Tool Title / Quick Inventory of Depressive Symptomatology (QIDS) /
Description / QIDS was developed to improve the available clinician and patient ratings by:
1)  Providing equivalent weightings (0-3) for each symptom item;
2)  Providing clearly stated anchors that estimate the frequency and severity of symptoms;
3)  Including all DSM-IV criterion items required diagnosing a major depressive episode;
4)  Providing matched clinician and patient ratings.
Setting / Multiple
NQF Number / none
Tool Developer / University of Pittsburgh Epidemiology Data Center
Link to tool specification / http://www.ids-qids.org/
Tool Link / QIDS-C: http://www.ids-qids.org/translations/english/QIDS-C%20English.pdf
QIDS-SR: http://www.ids-qids.org/translations/english/QIDS-SREnglish2page.pdf
Measure type / Standalone
Measure status / P4R - This measure requires prior authorization for use
Administration overview / The patient is asked to rate the items that best describes themselves over the last 7 days.
Administration: Available in two delivery formats:
·  QIDS-C Clinician administered interview: completed by a clinician or trained rater.
·  QIDS-SR Patient self-report: If patients are not able to confidently read the self-report versions, the clinician rated structured interview versions should be substituted, or the self-report can be read to the patient to assist him/her
Administration Time: 5 to 7 minutes
Language: English, Spanish, Turkish
Cost: Current translations of the pencil and paper versions of the QIDS are available at no cost to clinicians and researchers. Copies may be downloaded from this site and used without permission. The IDS and QIDS are available in an automated telephone-administered format (IVR) exclusively licensed to Health Technology Systems. Those wishing to consider the IVR versions should contact:
Healthcare Technology Systems, Inc.,
7617 Mineral Point Road, Suite 300,
Madison, Wisconsin, 53717.
Tel: 608-827-2419 or 800-316-2414;
e-mail:
Scoring / The QIDS-C16and the QIDS-SR16total scores range from 0 to 27. The total score is obtained by adding the scores for each of the nine symptom domains of the DSM-IV MDD criteria: depressed mood, loss of interest or pleasure, concentration/decision making, self-outlook, suicidal ideation, energy/fatigability, sleep, weight/appetite change, and psychomotor changes (Rush et al. 2003).
Sixteen items are used to rate the nine criterion domains of major depression: 4 items are used to rate sleep disturbance (early, middle, and late insomnia plus hypersomnia); 2 items are used to rate psychomotor disturbance (agitation and retardation); 4 items are used to rate appetite/weight disturbance (appetite increase or decrease and weight increase or decrease). Only one item is used to rate the remaining 6 domains (depressed mood, decreased interest, decreased energy, worthlessness/guilt, concentration/decision making, and suicidal ideation).
Each item is rated 0-3. For symptom domains that require more than one item, the highest score of the item relevant for each domain is taken. For example, if early insomnia is 0, middle insomnia is 1, late insomnia is 3, and hypersomnia is 0, the sleep disturbance domain is rated 3. The total score ranges from 0-2
QIDS-C16and QIDS-SR16
1.  Enter the highest score on any 1 of the 4 sleep items (items 1 to 4).
Enter the highest score on any 1 of the 4 weight items (items 6 to 9).
Enter the highest score on either of the 2 psychomotor items (15 and 16).
2.  There will be one score for each of the nine MDD symptom domains.
3.  Add the scores of the 9 items (sleep, weight, psychomotor changes, depressed mood, decreased interest, fatigue, guilt, concentration, and suicidal ideation) to obtain the "total score." Total scores range from 0-27.
Detailed scoring instructions can be found at: http://www.ids-qids.org/Scoring_Instructions.pdf
Additional Contacts / Healthcare Technology Systems, Inc.
7617 Mineral Point Road, Suite 300
Madison, Wisconsin, 53717.
Tel: 608-827-2419 or 800-316-2414
e-mail:
DSRIP-specific modifications to Measure Steward’s specification / None
Numerator Description / The sum of the "Total Score" of all QIDS screenings (Both QIDS-C and QIDS-SR) completed during the measurement period.
Numerator Inclusions / The survey developer does not identify specific numerator inclusions beyond what is described in the numerator description.
Numerator Exclusions / The survey developer does not identify specific numerator inclusions beyond what is described in the numerator description.
Denominator Description / The total number of QIDS screenings (both QIDS-C and QIDS-CR) completed during the measurement period.
Denominator Inclusions / The survey developer does not identify specific denominator inclusions beyond what is described in the denominator description.
Denominator Exclusions / The survey developer does not identify specific denominator exclusions beyond what is described in the denominator description.
Denominator Size / Providers must report a minimum of 30 cases per measure during a 12-month measurement period (15 cases for a 6-month measurement period)
·  For a measurement period (either 6 or 12-months) where the denominator size is less than or equal to 75, providers must report on all cases. No sampling is allowed.
·  For a measurement period (either 6 or 12-months) where the denominator size is less than or equal to 380 but greater than 75, providers must report on a random sample of not less than 76 cases.
·  For a measurement period (either 6 or 12-months) where the denominator size is greater than 380, providers must report on a random sample of cases that is not less than 20% of all cases; however, providers may cap the total sample size at 300 cases.
Denominator Sub-set Definition (Optional) / Providers have the option to further narrow the denominator population for this measure across one or more of the following domains. If providers wish to use this option, they must indicate their preference to HHSC through the measure selection process.
Payer: Providers may define the denominator population such that it is limited to one of the following options:
1.  Medicaid
2.  Uninsured/Indigent
3.  Both: Medicaid and Uninsured/Indigent
Gender: Providers may define the denominator population such that it is limited to one of the following options:
1.  Male
2.  Female
Ethnicity: Providers may define the denominator population such that it is limited to one of the following options:
1.  White/Caucasian
2.  Black/African American
3.  Latino/Hispanic
4.  Asian
5.  American Indian/Alaskan Native
6.  Native Hawaiian/Other Pacific Islander
Age: Providers may define the denominator population such that it is limited to an age range:
Lower Bound: ____ (Provider defined)
Upper Bound: ____ (Provider defined)
Comorbid Condition: Providers may define the denominator population such that it is limited to individuals with one or more comorbid conditions:
Comorbid condition: ______(Provider defined)
Setting/Location: Providers may define the denominator population such that it is limited to individuals receiving services in a specific setting or service delivery location(s).
Service Setting/Delivery Location(s): ______(Provider defined)
Provider Considerations / For DSRIP reporting purposes, QIDS-C and QIDS-SA scores can be treated as interchangeable instruments. Survey methodology will be evaluated by HHSC to ensure best fit.
Providers should for follow survey administration, sampling, and scoring guidelines, unless a DSRIP specific modification has been noted. Surveys are validated in their entirety and providers should plan on using as specified by the survey developer.
Data Source / Survey report/clinical data
Demonstration Years / DY3
10/01/13 – 09/30/14 / DY4
10/01/14 – 09/30/15 / DY5
10/01/15 – 09/30/16
Measurement Periods
(Note: For P4P measures, DY3 Measurement Period is equivalent to the Baseline Period for purposes of measuring improvement.) / Providers must report data for one of the following DY, SFY, or CY time periods:
12 Month Period:
1.  10/01/13 – 09/30/14, or
2.  09/01/13 – 08/31/14, or
3.  01/01/13 – 12/31/13, or
4.  10/01/12 – 09/30/13, or
5.  09/01/12 – 08/31/13
6 Month Period:
1.  04/01/14 – 09/30/14, or
2.  03/01/13 – 08/31/14, or
3.  01/01/13 – 06/30/13, or
4.  07/01/13 – 12/31/13
Other: Providers specify/propose an alternative 6 or 12 month time period to be reviewed and approved by HHSC. / Providers must report data across a 12-month time period that meets the following parameters:
1. Start date: The start date for the reporting period must occur after the provider’s DY3 Measurement Period.
2. End date: The end date for the reporting period must occur on or before 09/30/15. / Providers must report data across a 12-month time period that meets the following parameters:
1. Start date: The start date for the reporting period must occur after the provider’s DY4 Measurement Period.
2. End date: The end date for the reporting period must occur on or before 09/30/16.
Reporting Opportunities to HHSC / 10/31/2014 / 4/30/2015
10/31/2015 / 4/30/2016
10/31/2016